Allergan Drops Patent, Ad Claims Over Eyelash Drug Latisse
A California federal judge Thursday brought closer to an end Allergan Inc.'s long-running patent infringement and false advertising suit over its eyelash-enhancing drug Latisse after the company inked a deal that...To view the full article, register now.
Already a subscriber? Click here to view full article